Casp8p41 expression in primary T cells induces a proinflammatory response

AIDS

Volumn 24, Issue 9, 2010, Pages 1251-1258

  Taylor, Julie A ^a   Cummins, Nathan W ^a   Bren, Gary D ^a   Rizza, Stacey A ^a   Kolbert, Christopher P ^b   Behrens, Marshall D ^c   Knutson, Keith L ^c   Kahl, Jane C ^d   Asmann, Yan W ^d   Badley, Andrew D ^a  

^a Division of Infectious Diseases   (United States)

^b Advanced Genomic Technology Center   (United States)

^c Division of Immunology   (United Kingdom)

^d MAYO CLINIC   (United States)

Author keywords

Apoptosis; Casp8p41; HIV; Inflammation; Protease; Tumor necrosis factor

Indexed keywords

CASPASE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 5; PROTEIN CASP8P41; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; NF-KAPPA B; VIRUS REPLICATION;

EID: 77952958686     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283389e90     Document Type: Article

References (16)

1. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl JMed 1981; 305:1425-1431.
2. Reddy MM, Sorrell SJ, Lange M, Grieco MH. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. J Acquir Immune Defic Syndr 1988; 1:436-440.
3. Nie Z, Bren GD, Vlahakis SR, Schimnich AA, Brenchley JM, Trushin SA, et al. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol 2007; 81:6947-6956.
4. Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, et al. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ 2002; 9:1172-1184.
5. Algeciras-Schimnich A, Belzacq-Casagrande AS, Bren GD, Nie Z, Taylor JA, Rizza SA, et al. Analysis of HIV protease killing through caspase 8 reveals a novel interaction between caspase 8 and mitochondria. Open Virol J 2007; 1:39-46.
6. Bren GD, Whitman J, Cummins N, Shepard B, Rizza SA, Trushin SA, et al. Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS One 2008; 3:e2112.
7. Nie Z, Bren GD, Rizza SA, Badley AD. HIV protease cleavage of procaspase 8 is necessary for death of HIV-infected cells. Open Virol J 2008; 2:1-7.
8. Wu Z, Irizarry R, Gentleman R, Martinez-Murillo F, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004; 99:909-917.
9. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics 2004; 20:2778-2786.
10. Golks A, Brenner D, Krammer PH, Lavrik IN. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006; 203:1295-1305.
11. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001; 12:133-150.
12. Aukrust P, Muller F, Lien E, Nordoy I, Liabakk NB, Kvale D, et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antire-troviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999; 179:74-82.
13. Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, D'Aquila RT, et al. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an AIDS Clinical Trials Group study. J Infect Dis 2006; 194:1098-1107.
14. Kirkpatrick CH, Davis KC, Horsburgh CR Jr, Cohn DL, Penley K, Judson FN. Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome. J Clin Immunol 1985; 5:31-37.
15. Meyaard L, Hovenkamp E, Keet IP, Hooibrink B, de Jong IH, Otto SA, et al. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J Immunol 1996; 157:2712-2718.
16. BurkesRL,AboW,LevineAM,Linker-IsraeliM,ParkerJW,GillPS, et al. Characterization of immunologic function in homosexual menwithpersistent, generalizedlymphadenopathyandacquired immune deficiency syndrome. Cancer 1987; 59:731-738.